BerandaRGEN • NASDAQ
add
Repligen Corp
$166,14
Setelah Jam Perdagangan Normal:(0,00%)0,00
$166,14
Tutup: 29 Apr, 16.06.05 GMT-4 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$166,58
Rentang hari
$163,22 - $168,96
Rentang tahun
$110,45 - $211,13
Kapitalisasi pasar
9,28Â M USD
Volume Rata-Rata
450,66Â rb
Rasio P/E
225,28
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Des 2023info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 155,74Â jt | -16,61% |
Biaya operasional | 67,28Â jt | 4,56% |
Laba bersih | -25,49Â jt | -152,31% |
Margin laba bersih | -16,37 | -162,74% |
Penghasilan per saham | 0,33 | -51,47% |
EBITDA | 28,96Â jt | -37,18% |
Tarif pajak efektif | -191,06% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2023info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 751,32Â jt | 20,45% |
Total aset | 2,82Â M | 11,87% |
Total liabilitas | 853,21Â jt | 38,97% |
Total ekuitas | 1,97 M | — |
Saham yang beredar | 55,77 jt | — |
Harga terhadap reservasi | 4,71 | — |
Tingkat pengembalian aset | 0,75% | — |
Pengembalian modal | 0,79% | — |
Arus Kas
Perubahan bersih tunai
| (USD) | Des 2023info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -25,49Â jt | -152,31% |
Kas dari operasi | 29,06Â jt | -53,03% |
Tunai dari investasi | -169,90Â jt | -40,06% |
Tunai dari pembiayaan | 268,13Â jt | 97.956,57% |
Perubahan bersih tunai | 120,54Â jt | 341,55% |
Arus kas bebas | 14,42Â jt | -39,48% |
Tentang
Repligen is an American company devoted to the development and production of materials used in the manufacture of biological drugs. The company is based in Waltham, Massachusetts, and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. In February 2014, Repligen had employed 116 people, about 50% of these based in Sweden. Wikipedia
CEO
Didirikan
1981
Kantor pusat
Situs
Karyawan
1.783
